Literature DB >> 11900619

The ubiquitin-proteasome system and its role in ethanol-induced disorders.

Terrence M Donohue1.   

Abstract

Some of the most fundamental yet important cellular activities such as cell division and gene expression are controlled by short-lived regulatory proteins. The levels of these proteins are controlled by their rates of degradation. Similarly, protein catabolism plays a crucial role in prolonging cellular life by destroying damaged proteins that are potentially cytotoxic. A major player in these catabolic reactions is the ubiquitin-proteasome system, a novel proteolytic system that has become the primary proteolytic pathway in eukaryotic cells. Ubiquitin-mediated proteolysis is now regarded as the major pathway by which most intracellular proteins are destroyed. Equally important, from a toxicological standpoint, is that the ubiquitin-proteasome system is also widely considered to be a cellular defense mechanism, since it is involved in the removal of damaged proteins generated by adduct formation and oxidative stress. This review describes the history and the components of the ubiquitin-proteasome system, its regulation and its role in pathological states, with the major emphasis on ethanol-induced organ injury. The available literature cited here deals mainly with the effects of ethanol consumption on the ubiquitin-proteasome pathway in the liver. However, since this proteolytic system is an essential pathway in all cells it is an attractive experimental model and therapeutic target in extrahepatic organs such as the brain and heart that are also affected by excessive alcohol consumption.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900619     DOI: 10.1080/135562101200100562

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  9 in total

Review 1.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

2.  Ethanol enhances tau accumulation in neuroblastoma cells that inducibly express tau.

Authors:  Tania F Gendron; Sharon McCartney; Ena Causevic; Li-Wen Ko; Shu-Hui Yen
Journal:  Neurosci Lett       Date:  2008-07-24       Impact factor: 3.046

3.  Pathogenesis of alcoholic hepatitis: Role of inflammatory signaling and oxidative stress.

Authors:  Sarat C Jampana; Rashid Khan
Journal:  World J Hepatol       Date:  2011-05-27

4.  Lactobacillus rhamnosus CCFM1107 treatment ameliorates alcohol-induced liver injury in a mouse model of chronic alcohol feeding.

Authors:  Fengwei Tian; Feifei Chi; Gang Wang; Xiaoming Liu; Qiuxiang Zhang; Yongquan Chen; Hao Zhang; Wei Chen
Journal:  J Microbiol       Date:  2015-12-02       Impact factor: 3.422

5.  SAMe prevents the induction of the immunoproteasome and preserves the 26S proteasome in the DDC-induced MDB mouse model.

Authors:  Fawzia Bardag-Gorce; Joan Oliva; Jun Li; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2010-03-16       Impact factor: 3.362

Review 6.  Advances in alcoholic liver disease.

Authors:  Juliane I Beier; Gavin E Arteel; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2011-02

7.  Epigenetics of proteasome inhibition in the liver of rats fed ethanol chronically.

Authors:  Joan Oliva; Jennifer Dedes; Jun Li; Samuel-W French; Fawzia Bardag-Gorce
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

8.  Ethanol exposure alters protein expression in a mouse model of fetal alcohol spectrum disorders.

Authors:  Stephen Mason; Bruce Anthony; Xianyin Lai; Heather N Ringham; Mu Wang; Frank A Witzmann; Jin-Sam You; Feng C Zhou
Journal:  Int J Proteomics       Date:  2012-06-14

Review 9.  Focus on the liver: alcohol use, highly active antiretroviral therapy, and liver disease in HIV-infected patients.

Authors:  Shirish Barve; Rama Kapoor; Akshata Moghe; Julio A Ramirez; John W Eaton; Leila Gobejishvili; Swati Joshi-Barve; Craig J McClain
Journal:  Alcohol Res Health       Date:  2010
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.